Marc Beer is a successful businessman who heads the Renovia Inc. startup company as the CEO and co-founder. The company is set to launch a diverse number of new products that will be used in the treatment of pelvic floor disorder after it managed to raise a total of $42 million through Beer’s efforts. Renovia Inc. which is based in Boston seeks to develop a variety of the said products to be used in diagnostic and therapeutic procedures in pelvic floor disorder treatments in cases such as urinary incontinence among others. What’s more, with the launch of the new products will see the treatment of the pelvic floor disorders being of benefit to an estimated number of more than 250 million women in the world. Equally important, one of Renovia’s pioneer products known as Leva has already been approved by the FDA.
Further, the Long Wood Fund, an investment firm that specializes in the health sector is also part of the Series B round where it was preceded by the Perceptive Advisors Organization in New York and Ascension Ventures in Missouri. Furthermore, the funds collected will go a long way in the creation and development of four other diagnostic and therapeutic products that will include an improved Leva device. Marc Beer, the CEO of the Renovia said in a statement that the company was delighted to have some of the top healthcare investors supporting them besides sharing their vision of forming solutions for women with pelvic floor disorders. He added that with the teaming up of the given organizations, would stir innovation and technologies to help establish better digital platforms essential during the treatment options. Moreover, the new technologies will ultimately increase more information and understating in dealing with pelvic floor disorders and the general lowering of health costs.
About Marc Beer’s Career
As one of the respected businessman supporting a vital section in women’s health, Marc Beer has served in various capacities in the healthcare sector that include diagnostic, biotechnology and pharmaceutical industries. Also, with over 25 years of experience in the healthcare market place, his main are area of specialization has been in the development and commercialization of the above digital healthcare platforms. Having worked in several other companies, his latest achievement is when he co-founded Renovia alongside his partners Yolanda Lorie and Ramon Iglesias, who is the MD of the firm in 2016. Notably, it was shortly after starting the company, that Renovia Inc. began by closing the Series A financing when they combined efforts with some of the top healthcare ventures in the market. Other than that, Marc Beer has been in the frontline of making discoveries in the healthcare industry where such an example is when he was responsible for marketing JUXTAPID drug that received approval in more than 30 counties. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html